Literature DB >> 8978508

Modulation by neurosteroids of the in vivo (+)-[3H]SKF-10,047 binding to sigma 1 receptors in the mouse forebrain.

T Maurice1, F J Roman, A Privat.   

Abstract

Recent reports suggest an interaction between neuro-(active)steroids and sigma1 (sigma 1) receptors, affecting biochemical parameters as well as physiological responses mediated by sigma 1 ligands in the rodent brain. In this study, we examined the modulation by neurosteroids of the haloperidol-sensitive in vivo (+)-[3H]SKF-10,047 binding to sigma 1 sites in the mouse hippocampus and cortex. Progesterone (PROG; 2-40 mg/kg), pregnenolone sulfate (PREGS; 10-40 mg/kg), and dehydroepiandrosterone sulfate (DHEAS; 10-40 mg/kg) were administered systemically 10 min before the radioactive tracer. The total amount of (+)-[3H]SKF-10,047 bound in each structure was significantly affected by PROG and PREGS only at the highest dose tested and was unaffected by DHEAS. However, bound to free (B/F) radioactivity ratios were highly significantly decreased by 30-40% in each structure by PROG and PREGS. DHEAS, at 40 mg/kg, induced a significant 20% decrease in the hippocampus. Furthermore, the in vivo (+)-[3H]SKF-10,047 binding parameters were diminished in pregnant female mice compared to non-pregnant or male mice. These results confirm the in vitro binding results, bring a direct in vivo demonstration of the interaction between neurosteroids and sigma 1 receptors, and show that physiologic modulations of the steroidal concentrations affect the sigma 1 systems.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8978508     DOI: 10.1002/(SICI)1097-4547(19961215)46:6<734::AID-JNR10>3.0.CO;2-U

Source DB:  PubMed          Journal:  J Neurosci Res        ISSN: 0360-4012            Impact factor:   4.164


  21 in total

1.  Pregnancy reduces brain sigma receptor function.

Authors:  R Bergeron; C de Montigny; G Debonnel
Journal:  Br J Pharmacol       Date:  1999-08       Impact factor: 8.739

Review 2.  Sigma receptors: biology and therapeutic potential.

Authors:  Xavier Guitart; Xavier Codony; Xavier Monroy
Journal:  Psychopharmacology (Berl)       Date:  2004-06-10       Impact factor: 4.530

Review 3.  Neurosteroids: endogenous role in the human brain and therapeutic potentials.

Authors:  Doodipala Samba Reddy
Journal:  Prog Brain Res       Date:  2010       Impact factor: 2.453

Review 4.  Development of molecular probes for imaging sigma-2 receptors in vitro and in vivo.

Authors:  Robert Henry Mach; Kenneth Theodore Wheeler
Journal:  Cent Nerv Syst Agents Med Chem       Date:  2009-09

5.  Sigma receptors [σRs]: biology in normal and diseased states.

Authors:  Colin G Rousseaux; Stephanie F Greene
Journal:  J Recept Signal Transduct Res       Date:  2015-06-09       Impact factor: 2.092

Review 6.  The sigma-1 receptor as a regulator of dopamine neurotransmission: A potential therapeutic target for methamphetamine addiction.

Authors:  Danielle O Sambo; Joseph J Lebowitz; Habibeh Khoshbouei
Journal:  Pharmacol Ther       Date:  2018-01-31       Impact factor: 12.310

7.  The effect of the steroid sulfatase inhibitor (p-O-sulfamoyl)-tetradecanoyl tyramine (DU-14) on learning and memory in rats with selective lesion of septal-hippocampal cholinergic tract.

Authors:  P A Babalola; N F Fitz; R B Gibbs; P T Flaherty; P-K Li; D A Johnson
Journal:  Neurobiol Learn Mem       Date:  2012-09-26       Impact factor: 2.877

8.  TRPV1 channels and the progesterone receptor Sig-1R interact to regulate pain.

Authors:  Miguel Ortíz-Rentería; Rebeca Juárez-Contreras; Ricardo González-Ramírez; León D Islas; Félix Sierra-Ramírez; Itzel Llorente; Sidney A Simon; Marcia Hiriart; Tamara Rosenbaum; Sara L Morales-Lázaro
Journal:  Proc Natl Acad Sci U S A       Date:  2018-01-29       Impact factor: 11.205

9.  Steroid hormones affect binding of the sigma ligand 11C-SA4503 in tumour cells and tumour-bearing rats.

Authors:  Anna A Rybczynska; Philip H Elsinga; Jurgen W Sijbesma; Kiichi Ishiwata; Johan R de Jong; Erik F de Vries; Rudi A Dierckx; Aren van Waarde
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-02-27       Impact factor: 9.236

10.  Pharmacology and therapeutic potential of sigma(1) receptor ligands.

Authors:  E J Cobos; J M Entrena; F R Nieto; C M Cendán; E Del Pozo
Journal:  Curr Neuropharmacol       Date:  2008-12       Impact factor: 7.363

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.